Aboniki Balm - Topical Pain Relief Balm

Manufacturer
J C UDEOZOR & SONS GLOBAL INDUSTRIES LTD
Effective date
2022-12-26
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 21:42:54

Label at a glance#

ProductAboniki Balm - Topical Pain Relief Balm
Active ingredientEUCALYPTUS OIL, MENTHOL, METHYL SALICYLATE, CAMPHOR (SYNTHETIC)
Label structure15 sections

Indications and uses

Temporarily relieves minor aches & pains related to: arthritis simple backaches sore muscles joint pain dislocation leg cramps bruises sprains lumbago

Label contents#

Full prescribing information#

Drug Facts

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients (In each gram)

Camphor 5.04%

Eucalyptus Oil 2.30%

Menthol 5.10%

Methyl Salicylate 4.25%

Purpose

OTC - PURPOSE SECTION

Active Ingredients (In each gram) Purpose
Camphor 5.04%External Analgesic
Eucalyptus Oil 2.30%External Analgesic
Menthol 5.10%External Analgesic
Methyl Salicylate 4.25%External Analgesic

USES

INDICATIONS & USAGE SECTION

Temporarily relieves minor aches & pains related to:

  • arthritis
  • simple backaches
  • sore muscles
  • joint pain
  • dislocation
  • leg cramps
  • bruises
  • sprains
  • lumbago

Warning

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

  • on wounds or damaged skin
  • with a heating pad
  • if you are allergic to any of the ingredients

Ask a doctor or pharmacist before use if you have

OTC - ASK DOCTOR/PHARMACIST SECTION

  • sensitive skin
  • redness over the affected area

When using this product

OTC - WHEN USING SECTION

  • avoid contact with eyes and mucous membranes
  • do not bandage tightly

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • rash, itching, or excessive irritation of the skin develops
  • condition worsens or symptoms persist for more than 7 days
  • symptoms clear up and occur again within a few days

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Direction

DOSAGE & ADMINISTRATION SECTION

  • Use only as directed
  • For adults and children over 12 years, apply to the affected area 3 to 4 times daily
  • Wash hands after use
  • For Children under 12 years, consult a doctor before use

Other Information

OTHER SAFETY INFORMATION

  • Store in a cool, dry place between 20 oC to 25 oC (68 oF - 77 oF)
  • Do not use if the seal is broken
  • See cap for lot no, mfg, and exp date

Inactive Ingredients

INACTIVE INGREDIENT SECTION

FD&C Yellow No.6, Lanolin, Paraffin, White Petrolatum.

Contact Info

SPL UNCLASSIFIED SECTION

Distributed by:

J. C. Udeozor & Sons Global Industries Limited

Email:

Info-US@aboniki.com

Mail:

300 Delaware Ave, Suite 210 #465
Wilmington, DE 19801

USA

Aboniki ® Balm - Topical Pain Relief Balm - Twin Pack [Two 25g (0.88 OZ) Jar Inside]

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

  • New Look
  • Same Powerful Formula
  • Fast and Deep Penetrating Pain Relief

Aboniki Balm 2 PackAboniki Balm 2 Pack

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82729-00182729-001-01, 82729-001-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ffadedbd-7446-bdca-e053-6394a90adc8cde24a5a5-8780-ee4a-e053-2a95a90a961e2023-07-04WarningsExact identifier
spl set id: de24a5a5-8780-ee4a-e053-2a95a90a961e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.